- Email: [email protected]
4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
PATENT ABSTRACTS
642
pregnancy in cattle consisting of a glycoprotein obtained from a pregnant bovine animal which is characterized by having a specific immunological reaction with a monoclonal antibody directed specifically against said glycoprotein wherein said monoclonal antibody is produced from hybridoma ATCC HB 8846.
This invention teaches a method for determining the hormone cardiodilatin or active fragments thereof, well as antibodies thereto.
4897255 4895833 LIVER LACTOGENIC
FACTOR
L Stephen Frawley assigned to The Medical University of South Carolina The present invention relates to liver lactogenic factor and to its isolation, purification and characterization. The liver lactogenic factor of the present inventiofi is useful to increase rail and/or casein production in lactating female mammals. The invention additionally pertains to a novel bioassay capable of identifying lactogenic factors.
4895864 ANTIBIOTIC TAN-950A, ITS PRODUCTION AND USE Takashi Iwasa, Shigetosh Tsubotani, Setsuo Harada, Kyoto, Japan assigned to Takeda Chemical Industries Ltd As the novel antibiotic TAN-950A having the structural formula See Patent for Chemical Structure and salt thereof of the present invention show antimicrobial action against fungi, they can be used in the therapeutics of fungal infections, in human and other animals etc. by oral, parenteral or external administration.
4895992 METHOD FOR DETERMINING CARDIODILATIN AND FRAGMENTS THEREOF AND ANTIBODIES USEFUL IN DETERMINATION OF CARDIODILATIN AND ITS FRAGMENTS Wolf-Georg Forssmann, Heidelberg, Federal Republic Of Germany assigned to Organogen Medizinisch Molekularbiologische Forschungsgesellschaft m b H
METAL RADIONU(~LIDE LABELED PROTEINS FOR DIAGNOSIS AND THERAPY Alan R Fritzberg, Sudhaka Kasina, Ananthachari Srinivasan, Daniel S Wilbur assigned to NeoRx Corporation Protein conjugated chelated metal radionuclides are provided for use in vivo. Intermediates are provided for preparing the polypeptide compositions efficiently.
4897264 HUMAN GAMMA INTERFERONSPECIFIC RECEPTOR PROTEIN, ANTIBODY AGAINST SAID PROTEIN, METHODS FOR OBTAINING SAID PROTEIN AND SAID ANTIBODY AND COMPOSITIONS CONTAINING SAID PROTEIN AND ANTIBODY Daniel Novick, Patricia Orchansky, Dina Fischer, Menache Rubinstein, Rehovot, Israel assigned to Yeda Research and Development Co Ltd Analysis of (125I). interferon gamma crnsslinked to its receptor on various human cells by SDS-PAGE revealed that there are at least three different types of human interferon gamma receptors. In WISH, HeLa, FSI 1 and the other tissue cells an Mr 90,000-105,000 receptor was found. In monocytes and in the myeloid cell line KG-1 an Mr 140,000 receptor was found while in Daudi lymphoblastoid cells an Mr 95,000115,000 receptor was found. The various receptors were isolated from these cells by extraction followed by affinity chromotography on an immobilized interferon gamma column. The resulting purified preparations retained their original affinity for interferon gamma and were used for immunizing mice and subsequent development of highly specific antibodies.
642
pregnancy in cattle consisting of a glycoprotein obtained from a pregnant bovine animal which is characterized by having a specific immunological reaction with a monoclonal antibody directed specifically against said glycoprotein wherein said monoclonal antibody is produced from hybridoma ATCC HB 8846.
This invention teaches a method for determining the hormone cardiodilatin or active fragments thereof, well as antibodies thereto.
4897255 4895833 LIVER LACTOGENIC
FACTOR
L Stephen Frawley assigned to The Medical University of South Carolina The present invention relates to liver lactogenic factor and to its isolation, purification and characterization. The liver lactogenic factor of the present inventiofi is useful to increase rail and/or casein production in lactating female mammals. The invention additionally pertains to a novel bioassay capable of identifying lactogenic factors.
4895864 ANTIBIOTIC TAN-950A, ITS PRODUCTION AND USE Takashi Iwasa, Shigetosh Tsubotani, Setsuo Harada, Kyoto, Japan assigned to Takeda Chemical Industries Ltd As the novel antibiotic TAN-950A having the structural formula See Patent for Chemical Structure and salt thereof of the present invention show antimicrobial action against fungi, they can be used in the therapeutics of fungal infections, in human and other animals etc. by oral, parenteral or external administration.
4895992 METHOD FOR DETERMINING CARDIODILATIN AND FRAGMENTS THEREOF AND ANTIBODIES USEFUL IN DETERMINATION OF CARDIODILATIN AND ITS FRAGMENTS Wolf-Georg Forssmann, Heidelberg, Federal Republic Of Germany assigned to Organogen Medizinisch Molekularbiologische Forschungsgesellschaft m b H
METAL RADIONU(~LIDE LABELED PROTEINS FOR DIAGNOSIS AND THERAPY Alan R Fritzberg, Sudhaka Kasina, Ananthachari Srinivasan, Daniel S Wilbur assigned to NeoRx Corporation Protein conjugated chelated metal radionuclides are provided for use in vivo. Intermediates are provided for preparing the polypeptide compositions efficiently.
4897264 HUMAN GAMMA INTERFERONSPECIFIC RECEPTOR PROTEIN, ANTIBODY AGAINST SAID PROTEIN, METHODS FOR OBTAINING SAID PROTEIN AND SAID ANTIBODY AND COMPOSITIONS CONTAINING SAID PROTEIN AND ANTIBODY Daniel Novick, Patricia Orchansky, Dina Fischer, Menache Rubinstein, Rehovot, Israel assigned to Yeda Research and Development Co Ltd Analysis of (125I). interferon gamma crnsslinked to its receptor on various human cells by SDS-PAGE revealed that there are at least three different types of human interferon gamma receptors. In WISH, HeLa, FSI 1 and the other tissue cells an Mr 90,000-105,000 receptor was found. In monocytes and in the myeloid cell line KG-1 an Mr 140,000 receptor was found while in Daudi lymphoblastoid cells an Mr 95,000115,000 receptor was found. The various receptors were isolated from these cells by extraction followed by affinity chromotography on an immobilized interferon gamma column. The resulting purified preparations retained their original affinity for interferon gamma and were used for immunizing mice and subsequent development of highly specific antibodies.